As shown in Figure 5B, human CD8+ TIL prepared from lung cancer patients and activated (anti-CD3/IL-2) in the presence of TWS119 for five days displayed a distinct population of CD45RAint/CD62L+ cells. The gene discussed is IL2; the disease is lung cancer.